Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1Phase 2 1

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other 2Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 1059Neoplasms 885Prostatic Neoplasms 510Lung Neoplasms 426Colorectal Neoplasms 358Motor Activity 226Uterine Cervical Neoplasms 194Head and Neck Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 174Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 136Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 115Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Endometrial Neoplasms 87Glioblastoma 86Disease 85Lymphoma 84Sarcoma 78

Interventions

Diet, Ketogenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Non-alcoholic Fatty Liver Disease × 1 year × Clear all
NCT05884723 2026-05-19

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

Western University, Canada

Phase NA Recruiting
124 enrolled

Fatty Liver, Non-alcoholic Fatty Liver Disease

NCT07146815 2025-08-28

P-CORIGA

Ziekenhuis Oost-Limburg

Phase NA Completed
157 enrolled

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

NCT04186260 2025-08-24

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

University of Arizona

Phase NA Completed
15 enrolled
EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Overweight, Non-alcoholic Fatty Liver Disease

NCT01047735 2025-07-11

TRIABETES

University of Pittsburgh

Phase NA Active not recruiting
69 enrolled
Other

Behavior, Blindness, Body Weight, Cardiovascular Diseases, Death, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Disease, Hypertension, Inflammation, Insulin Resistance, Liver Diseases, Motor Activity, Myocardial Infarction, Neoplasms, Obesity, Obesity, Morbid, Weight Loss, Atherosclerosis, Renal Insufficiency, Non-alcoholic Fatty Liver Disease

NCT06366425 2025-07-10

HEPGEN

University Hospital, Montpellier

Phase NA Recruiting
260 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡